The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 24, 2020

Filed:

Sep. 05, 2014
Applicant:

President and Fellows of Harvard College, Cambridge, MA (US);

Inventors:

David R. Liu, Lexington, MA (US);

Johnny Hao Hu, Cambridge, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); C12N 15/115 (2010.01); C12N 15/90 (2006.01); C12N 9/22 (2006.01); C12N 15/01 (2006.01); C12N 9/96 (2006.01); C12N 15/10 (2006.01); C12N 15/63 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/907 (2013.01); C12N 9/22 (2013.01); C12N 9/96 (2013.01); C12N 15/01 (2013.01); C12N 15/102 (2013.01); C12N 15/113 (2013.01); C12N 15/115 (2013.01); C12N 15/63 (2013.01); A61K 48/00 (2013.01); C12N 2310/10 (2013.01); C12N 2310/12 (2013.01); C12N 2310/16 (2013.01); C12N 2310/3519 (2013.01); C12N 2310/53 (2013.01); C12N 2320/53 (2013.01); C12Y 301/00 (2013.01);
Abstract

Some aspects of this disclosure provide compositions, methods, systems, and kits for controlling the activity and/or improving the specificity of RNA-programmable endonucleases, such as Cas9. For example, provided are guide RNAs (gRNAs) that are engineered to exist in an 'on' or 'off state, which control the binding and hence cleavage activity of RNA-programmable endo-nucleases. Some aspects of this disclosure provide mRNA-sensing gRNAs that modulate the activity of RNA-programmable endo-nucleases based on the presence or absence of a target mRNA. Some aspects of this disclosure provide gRNAs that modulate the activity of an RNA-programmable endonuclease based on the presence or absence of an extended DNA (xDNA).


Find Patent Forward Citations

Loading…